OpenAI introduces MedChemBench to test AI on medicinal chemistry reasoning
OpenAI introduced MedChemBench, a benchmark of 99 problems drawn from published research that tests whether AI models can connect molecular structure with experimental evidence. The problems draw on 117 papers and patents and include 761 distinct molecular structures. At the xhigh reasoning setting, GPT-6.2 Astra earned 84.5% of the available credit, compared with 83.3% for GPT-6 Astra and 58.2% for GPT-5.6 Sol. OpenAI says the results do not establish whether models can discover new drugs or improve laboratory decisions.